Physician
Oncology
Dr. Zeba Aziz, MD
Zeba Aziz, MD is an expert in the field of Oncology. Dr. Zeba Aziz is a published doctor and has 24 publications published. The lastest was: 'Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies.'
Publications
- Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapies.
- Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia.
- Survival of women with locally advanced breast cancer at a teaching hospital in Lahore.
- Sustained superior long-term outcomes and cytogenetic responses with imatinib mesylate in chronic phase chronic myeloid leukaemia: report from a developing country.
- Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast ca...
- Worsened oncologic outcomes for women of lower socio-economic status (SES) treated for locally advanced breast cancer (LABC) in Pakistan.
- Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemothe...
- The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30.
- Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving c...
- The need for an effective palliative care strategy in Pakistan.
- Phase III, double-blind, randomized study comparing lapatinib plus paclitaxel with placebo plus paclitaxel as first-line treatment for metastatic breast cancer.
- Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries.
- Across generations: cancer treatment in developing countries.
- Effect of social class disparities on disease stage, quality of treatment and survival outcomes in breast cancer patients from developing countries.
- Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer.
- Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.
- Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country.
- Breast cancer in limited-resource countries: treatment and allocation of resources.
- Applicability of international prognostic index in non Hodgkin''s lymphoma in Pakistan.
- Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder.
- Prospective evaluation of efficacy and toxicity of 5-fu and folinic acid (Mayo Clinic regimen) in patients with advanced cancer of the gallbladder.
- Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan.
- Cancer treatment in Pakistan: challenges & obstacles.
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
North Shore-Long Island Jewish Health System
Helpful Reviews
Similar Doctors
|
Dr. Laronna S. Colbert, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hiba Tamim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lloyd G. Geddes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gurinderjit K. Sidhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcel E. Conrad Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig S. Campus, MD |
|
|
Dr. Emiliana L. San Diego, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abid Mohiuddin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haig S. Yardumian, DO |